| [1] |
HUANG Haozhe, CHEN Hong, ZHENG Dezhong, CHEN Chao, WANG Ying, XU Lichao, WANG Yaohui, HE Xinhong, YANG Yuanyuan, LI Wentao.
A CT-based radiomics nomogram for predicting local tumor progression of colorectal cancer lung metastases treated with radiofrequency ablation
[J]. China Oncology, 2024, 34(9): 857-872.
|
| [2] |
PAN Jian, YE Dingwei, ZHU Yao, WANG Beihe.
Correlation analysis of PSMA PET/CT-derived parameters and circulating tumor DNA features in patients with hormone-sensitive prostate cancer
[J]. China Oncology, 2024, 34(7): 680-685.
|
| [3] |
JIANG Tiaoyan, JIA Tianying, ZHANG Qin.
Contrast-enhanced computed tomography-based radiomics models for the risk categorization of thymoma
[J]. China Oncology, 2024, 34(6): 581-589.
|
| [4] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
| [5] |
LIU Qi, CHANG Cai, LI Jiawei.
Research progress on the correlation between imaging features and the molecular subtype, histopathology, clinical prognosis of ductal carcinoma in situ of the breast
[J]. China Oncology, 2024, 34(2): 201-209.
|
| [6] |
LIU Wei, XIE Tiansong, CHEN Lei, ZHANG Zehua, ZHOU Zhengrong.
Investigating the value of dual-layer spectral detector CT in distinguishing resectable pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis
[J]. China Oncology, 2024, 34(1): 67-73.
|
| [7] |
YANG Ziyi, GU Bingxin, XU Xiaoping, SONG Shaoli.
Comparison of 18F-FDG and 68Ga-FAPI PET/CT in the diagnosis of lung metastasis in different malignant tumors
[J]. China Oncology, 2023, 33(9): 829-833.
|
| [8] |
JIA Liqing, GE Xiaolu, JIANG Lin, ZHOU Xiaoyan.
Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma
[J]. China Oncology, 2023, 33(8): 717-725.
|
| [9] |
DONG Hao, QIU Yonggang, WANG Xinbin, YANG Junjie, LOU Cuncheng, YIN Lekang, YE Xiaodan.
Predictive value of logistic regression model based on high-resolution CT signs for high-grade pattern in stage ⅠA lung adenocarcinoma
[J]. China Oncology, 2023, 33(8): 768-775.
|
| [10] |
LIU Xiaoli, CHAI Wenjun, SUN Lei, YAN Mingxia, PAN Hongyu, SUN Yuexi.
Analysis of differential splicing gene by regulation of splicing regulatory protein KHSRP in lung adenocarcinoma
[J]. China Oncology, 2023, 33(7): 637-645.
|
| [11] |
WANG Yan, SU Yue, HU Tu, LIU Qiying, YAO Weiqiang, CHEN Yong, YAN Wangjun, ZHANG Zhen.
Retrospective analysis of short-term efficacy and safety of preoperative radiotherapy for 33 cases of locally high-risk soft tissue sarcoma
[J]. China Oncology, 2023, 33(7): 693-700.
|
| [12] |
CHEN Ruchuan, LIU Wei, ZHOU Bingni, LIU Xiaohang, ZHOU Liangping.
The value of VI-RADS combined with tumor contact length in the detection of muscle-invasive bladder cancer
[J]. China Oncology, 2023, 33(3): 260-266.
|
| [13] |
MU Jiaqian, TENG Xiaoyan, WEI Lirong, QIU Rong, GUI Pengcheng, DU Yuzhen.
The role and application value of integrin β3 in bone metastasis of lung adenocarcinoma
[J]. China Oncology, 2022, 32(4): 351-356.
|
| [14] |
ZHU Haipeng, HU Jun, JIANG Min, CAI Ruonan, WANG Junqiao, LI Li.
A study on mechanism of GOLM1 regulating PI3K/AKT/mTOR signaling pathway to promote proliferation, invasion and migration of lung adenocarcinoma cells
[J]. China Oncology, 2022, 32(3): 207-217.
|
| [15] |
ZHOU Bingni, LIU Xiaohang, GU Bingxin, ZHOU Liangping, GU Yajia.
The value of mpMRI combined with 99mTc-PSMA SPECT/CT in the detection of significant residual prostate cancer after neoadjuvant androgen deprivation therapy
[J]. China Oncology, 2022, 32(2): 134-141.
|
